France Biotechnology & Medical Research

Genoway SA (ALGEN)

Genoway SA experienced notable insider trading activity recently, characterized by consistent purchasing from CEO Alexandre Fraichard. Over the past ninety days, he acquired shares totaling approximately 268,739 EUR. This accumulation occurs amid a 15.8% decline in stock performance, following the company's latest September earnings report.
Ticker: ALGEN Exchange: PAR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Genoway SA. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.6
Alexandre Fraichard DG Officer
Transaction date
Purchase
Price
44.31
Quantity 44,353
Value €1,549,959
3.6
Alexandre Fraichard DG Officer
Transaction date
Purchase
Price
498.25
Quantity 65,525
Value €338,727
3.6
Alexandre Fraichard DG Officer
Transaction date
Purchase
Price
397.32
Quantity 74,096
Value €2,473,749
3.6
Alexandre Fraichard DG Officer
Transaction date
Purchase
Price
2.35
Quantity 80,999
Value €190,214
3.6
Alexandre Fraichard DG Officer
Transaction date
Purchase
Price
2.50
Quantity 35,850
Value €89,482
3.6
Alexandre Fraichard DG Officer
Transaction date
Purchase
Price
2.42
Quantity 25,000
Value €60,500
ISTYA FOND DE DOTATION ADMINISTRATEUR Director
Transaction date
Sale
Price
2.40
Quantity 4,870
Value €11,688
SOLYS SARL ADMINISTRATEUR Director
Transaction date
Sale
Price
2.40
Quantity 4,900
Value €11,760
CARLYS SOCIETE CIVILE ADMINISTRATEUR Director
Transaction date
Sale
Price
2.40
Quantity 10,000
Value €24,000
SOLYS SARL ADMINISTRATEUR Director
Transaction date
Purchase
Price
2.40
Quantity 5,000
Value €12,000
2.1
JEAN LOUIS MENARD ADMINISTRATEUR Director
Transaction date
Sale
Price
2.40
Quantity 4,044
Value €9,706
2.1
JEAN LOUIS MENARD ADMINISTRATEUR Director
Transaction date
Purchase
Price
2.35
Quantity 38,500
Value €90,475
2.7
olivier Charmeil Administrateur Indépendant Non-Executive Director
Transaction date
Purchase
Price
2.35
Quantity 42,553
Value €100,000
3.6
Florent Pons Directeur Marketing Officer
Transaction date
Purchase
Price
2.80
Quantity 484
Value €1,355
3.6
Florent Pons Directeur Marketing Officer
Transaction date
Purchase
Price
2.80
Quantity 516
Value €1,445
3.6
Alexandre Fraichard Directeur General Officer
Transaction date
Purchase
Price
3.07
Quantity 11,299
Value €34,687
3.6
Alexandre Fraichard Directeur Général Officer
Transaction date
Purchase
Price
3.04
Quantity 12,500
Value €38,054
3.6
Florent Pons Directeur des Opérations Commerciales Officer
Transaction date
Sale
Price
3.90
Quantity 3,880
Value €15,132
3.6
Florent Pons Directeur des Opérations Commerciales Officer
Transaction date
Sale
Price
4.80
Quantity 1,700
Value €8,160
3.8
Christian Grenier Président du CA Director
Transaction date
Sale
Price
4.40
Quantity 5,000
Value €22,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-11-02 2026-10-30 B Purchase
3.6
Alexandre Fraichard

DG

Officer
44,353
44.31
€1,549,959 		44,353 44.31 €1,549,959
2026-10-26 2026-10-23 B Purchase
3.6
Alexandre Fraichard

DG

Officer
65,525
498.25
€338,727 		65,525 498.25 €338,727
2026-10-12 2026-10-10 B Purchase
3.6
Alexandre Fraichard

DG

Officer
74,096
397.32
€2,473,749 		74,096 397.32 €2,473,749
2026-09-30 2026-09-29 B Purchase
3.6
Alexandre Fraichard

DG

Officer
80,999
2.35
€190,214 		80,999 2.35 €190,214
2026-07-29 2026-07-27 B Purchase
3.6
Alexandre Fraichard

DG

Officer
35,850
2.50
€89,482 		35,850 2.50 €89,482
2026-07-20 2026-07-16 B Purchase
3.6
Alexandre Fraichard

DG

Officer
25,000
2.42
€60,500 		25,000 2.42 €60,500
2026-06-22 2026-06-17 S Sale ISTYA FOND DE DOTATION

ADMINISTRATEUR

Director
4,870
2.40
€11,688 		4,870 2.40 €11,688
2026-06-22 2026-06-17 S Sale SOLYS SARL

ADMINISTRATEUR

Director
4,900
2.40
€11,760 		4,900 2.40 €11,760
2026-06-22 2026-06-17 S Sale CARLYS SOCIETE CIVILE

ADMINISTRATEUR

Director
10,000
2.40
€24,000 		10,000 2.40 €24,000
2026-06-22 2026-05-28 B Purchase SOLYS SARL

ADMINISTRATEUR

Director
5,000
2.40
€12,000 		5,000 2.40 €12,000
2026-05-29 2026-05-28 S Sale
2.1
JEAN LOUIS MENARD

ADMINISTRATEUR

Director
4,044
2.40
€9,706 		4,044 2.40 €9,706
2025-12-23 2025-12-17 B Purchase
2.1
JEAN LOUIS MENARD

ADMINISTRATEUR

Director
38,500
2.35
€90,475 		38,500 2.35 €90,475
2025-12-19 2025-12-17 B Purchase
2.7
olivier Charmeil

Administrateur Indépendant

Non-Executive Director
42,553
2.35
€100,000 		42,553 2.35 €100,000
2025-04-15 2025-04-11 B Purchase
3.6
Florent Pons

Directeur Marketing

Officer
484
2.80
€1,355 		484 2.80 €1,355
2025-04-15 2025-04-11 B Purchase
3.6
Florent Pons

Directeur Marketing

Officer
516
2.80
€1,445 		516 2.80 €1,445
2025-04-02 2025-03-31 B Purchase
3.6
Alexandre Fraichard

Directeur General

Officer
11,299
3.07
€34,687 		11,299 3.07 €34,687
2025-01-31 2025-01-31 B Purchase
3.6
Alexandre Fraichard

Directeur Général

Officer
12,500
3.04
€38,054 		12,500 3.04 €38,054
2024-09-30 2024-09-25 S Sale
3.6
Florent Pons

Directeur des Opérations Commerciales

Officer
3,880
3.90
€15,132 		3,880 3.90 €15,132
2024-01-18 2024-01-17 S Sale
3.6
Florent Pons

Directeur des Opérations Commerciales

Officer
1,700
4.80
€8,160 		1,700 4.80 €8,160
2023-12-18 2023-12-15 S Sale
3.8
Christian Grenier

Président du CA

Director
5,000
4.40
€22,000 		5,000 4.40 €22,000

See older Genoway SA insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Genoway SA history with Plus

Billed monthly · Cancel anytime

Explore more

More insider trading research around Genoway SA

More insider trades in France
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe